The MPX combines different imaging techniques in one easy-to-use and portable device: non-linear MP (two-photon, SHG & THG) and widefield epi-fluorescence and fluorescence lifetime imaging to maximize informational content, ranging from single cells up to living animals.
Our mission focuses on continuously advancing the understanding of human biology and generating actionable insights on prospective drug candidates. Our interdisciplinary team is enabling the production of 3D cell culture in vitro models and organ chips that mimic human biology. Our expertise and commitment propel novel, rapid, and safe drug discovery for life-threatening diseases using our comprehensive suite of products and services.
X-Light V3 is the next generation of X-Light spinning disk confocal series. It relies on the cutting-edge technology, advanced optical design approach and engineering solutions developed by CrestOptics to meet the very high-end specifications required by most of the modern fluorescence microscopy applications.
3D Cell Culture Bioreactor CERO 3D.
The CERO 3D Incubator & Bioreactor is a new, revolutionary instrument creating optimal cell culture environment. It offers a special 3D cell culture technology that monitors and controls temperature, pH and carbon dioxide levels. Indeed, this is ideal for stem cells, spheroids, organoids and even tissues.
LAB WEIGHING AND SORTING FOR
ORGANOIDS AND SPHEROIDS
From quality control to drug activity effect, from compactness-related data to highlighting permeation, the W8 represents a novel approach to cover worldwide claimed scientific gaps related to the need for improvements in 3D cell cultures. Uniformity and standardization, as well as growth monitoring and protocol modifications effects, have been challenging for researchers. The W8 not only gives new perspectives on such aspects, but it does so label-free, with preserved sterility and viability and allowing a unique biophysical-based sorting of the subpopulation suitable to continue your workflow.
Progress Oncology Drug Development with Organoids Developed using HUB Protocols Incorporate the most translatable 3D in vitro models available into your oncology drug development programs. We exclusively provide preclinical oncology drug development and validation services using unique organoid models developed using IP-protected Hubrecht Organoid Technology (HUB) protocols, as well as HUB’s biobank of already established patient-derived organoids (PDO).
The Incucyte® Organoid Assay uses an established protocol and purpose-built software, for continuous acquisition and objective analysis of organoid size, count and morphology in a microplate format all from inside your incubator.
Round up of the latest technology and research